Engaged in the Development of Novel Drugs and Therapies for the Treatment of People With Cancer
Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer. On January 28, 1997 Coulter Pharamaceutical went public. In 2000, Coulter Pharmaceutical was bought by Corixa Corp.
Our team seeks out the most promising entrepreneurs and opportunities. Get in touch with us!
© 2023 BLACK DIAMOND VENTURES